YHLO

YHLO Focus on healthcare, better life with technology In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.

Getting Closer: Autoimmunity 2026 Starts in 72 HoursYHLO is ready for Prague. We're counting down to an exciting week of...
11/05/2026

Getting Closer: Autoimmunity 2026 Starts in 72 Hours

YHLO is ready for Prague. We're counting down to an exciting week of science, collaboration, and discovery.

⏰ Date: 14–17 May 2026
📍 Venue: Prague Congress Centre, Czech Republic
📍 Full Address: 5. kvetna 1640/65, Nusle, 140 21 Prague
📣 Booth: # NO. 9

We look forward to meeting you, hearing your perspectives, and discussing how our platforms can fit into your workflow.

Have questions? Curious about how we approach autoimmunity testing? Stop by. Let's talk. 💬

🔗 Learn more about YHLO: https://en.szyhlo.com

She shaped our world with love and patience. 🎈 Today, we say it simply: Thank you, Mom. 🎇 Happy Mother's Day. 💐 Thank yo...
10/05/2026

She shaped our world with love and patience. 🎈
Today, we say it simply: Thank you, Mom. 🎇

Happy Mother's Day. 💐
Thank you for always being there. 🎉

World Lupus Day 2026: Make Lupus VisibleLupus is a chronic, autoimmune disease that can damage any part of the body (ski...
10/05/2026

World Lupus Day 2026: Make Lupus Visible

Lupus is a chronic, autoimmune disease that can damage any part of the body (skin, joints, and/or organs inside the body). This "invisible disease" is not always easy to recognize. But the people who live with it deserve to be seen. 💜

YHLO supports the clinicians who face these diagnostic challenges every day with reliable autoantibody testing. We stand with lupus patients and the teams who bring answers and hope. 💡

Connective Tissue Disease: A Broad Autoantibody Profile for a Complex Diagnosis 🧬 Connective tissue diseases share overl...
08/05/2026

Connective Tissue Disease: A Broad Autoantibody Profile for a Complex Diagnosis 🧬

Connective tissue diseases share overlapping clinical features, but their serological signatures are distinct. That is why broad-spectrum autoantibody profiling matters.

Our panel covers a comprehensive range of CTD-relevant markers. For the full parameter list, please see the poster.

YHLO panel brings clarity to complex CTD cases. 💡

🔗 Learn more about YHLO: https://en.szyhlo.com

Autoimmunity 2026: Prague Awaits 📣 The global autoimmune community is gathering in Prague from 14–17 May. YHLO is proud ...
07/05/2026

Autoimmunity 2026: Prague Awaits 📣

The global autoimmune community is gathering in Prague from 14–17 May. YHLO is proud to join this important dialogue with our CLIA, LIA, and IFA platforms.

⏰ Date: 14–17 May 2026
📍 Venue: Prague Congress Centre, Czech Republic
📍 Full Address: 5. kvetna 1640/65, Nusle, 140 21 Prague
📣 Booth: # NO. 9

More details to come. Save the date. 🎉 💪

🔗 Learn more about YHLO: https://en.szyhlo.com

World Hand Hygiene Day 2026: Action Saves LivesHand hygiene is the simplest, most effective way to stop the spread of in...
05/05/2026

World Hand Hygiene Day 2026: Action Saves Lives

Hand hygiene is the simplest, most effective way to stop the spread of infections and protect patients. YHLO joins this global movement. Because safer healthcare starts with clean hands.

One small action, repeated every day, saves countless lives.

Uncovering RA: How a Broader Panel Supports Clinical ConfidenceThe serological presentation of rheumatoid arthritis is h...
03/05/2026

Uncovering RA: How a Broader Panel Supports Clinical Confidence

The serological presentation of rheumatoid arthritis is highly heterogeneous. A significant proportion of patients test negative for conventional autoantibody markers, making reliance on any single test an unreliable strategy for either confirming or excluding the diagnosis.
A multi-marker panel is therefore essential for supporting a more comprehensive clinical evaluation.

✔️ Our panel brings together Anti-CCP, RF IgG, RF IgM, RF IgA** (**Coming Soon), RF, and RA33 IgG — each providing a different layer of serological insight.

By moving beyond single-marker testing, clinicians can achieve a clearer, more confident diagnostic assessment.

🔗 Learn more about YHLO: https://en.szyhlo.com

On this sacred day of Vesak, we honor the timeless values of peace, kindness, and respect for all beings.A peaceful Vesa...
01/05/2026

On this sacred day of Vesak, we honor the timeless values of peace, kindness, and respect for all beings.

A peaceful Vesak to all who celebrate. ✨

You don't work for applause. But today, we applaud you anyway. ☀️ Your hands move the world forward. 🎉 💪 Happy Internati...
01/05/2026

You don't work for applause.
But today, we applaud you anyway. ☀️
Your hands move the world forward. 🎉 💪

Happy International Labour Day. 💐 🎇

📅 The international congress on autoimmunity is gathering in Prague — and YHLO will be there. We invite you to visit YHL...
30/04/2026

📅 The international congress on autoimmunity is gathering in Prague — and YHLO will be there.

We invite you to visit YHLO Booth # NO. 9 to explore our autoimmune diagnostic solutions.

⏰ Date: 14–17 May 2026
📍Venue: Prague Congress Centre, Czech Republic
📍Full Address: 5. kvetna 1640/65, Nusle, 140 21 Prague
📣 Booth: # NO. 9

Let's move diagnostics forward — together.

🔗 Learn more about YHLO: https://en.szyhlo.com

YHLO Joins BSI's 125th Anniversary Gala in LondonOn April 23, YHLO Founder Mr. Hu Deming and Chairman Mr. Hu Kunhui atte...
28/04/2026

YHLO Joins BSI's 125th Anniversary Gala in London

On April 23, YHLO Founder Mr. Hu Deming and Chairman Mr. Hu Kunhui attended BSI's 125th anniversary gala in London as the only Chinese IVD representatives.

YHLO & BSI: Regulatory Milestones:
🔹 2020 - Initiated CE certification collaboration with BSI.
🔹 2022 - Received first MDSAP certificate from BSI.
🔹 2023 - Dr. Michael Weissig, Global Managing Director Medical Devices (Regulatory Services) at BSI Group, visited YHLO, enabling all YHLO CLIA products to transition from IVDD CE to IVDR CE.
🔹 2025 - Dr. Michael Weissig's second visit, marking YHLO as the first Chinese IVD manufacturer to achieve full IVDR CE for the entire blood bank panel
🔹 To date - 200 YHLO products have obtained IVDR CE certification from BSI, placing YHLO at the forefront of the industry

YHLO now operates seven overseas service centers and offices, with products sold in over 120 countries.

Our mission —“Focus on healthcare, better life with technology” — drives us to make quality diagnostics accessible worldwide. 💪

🔗 Learn more about YHLO: https://en.szyhlo.com

Address

YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict
Shenzhen
518000

Telephone

+8675526601910

Website

Alerts

Be the first to know and let us send you an email when YHLO posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to YHLO:

Shortcuts

Share

Category